Literature DB >> 10320602

Ropivacaine 0.25% compared with bupivacaine 0.25% by the caudal route.

M J Da Conceicao1, L Coelho, M Khalil.   

Abstract

We compared in a randomized double-blind study, the postoperative analgesia and degree of motor block produced by the new local anaesthetic ropivacaine, with bupivacaine, for caudal anaesthesia in children. Eighty children, 2-5-years-old, ASA I, received one of two local anaesthetics; either ropivacaine 0.25% (1.0 ml x kg(-1)) or bupivacaine 0.25% (1.0 ml x kg(-1)). They were sedated with a continuous infusion of propofol (200 microg x kg(-1) min(-1). The lungs were ventilated with a mixture of 50% nitrous oxide with oxygen. 60 min after local anaesthetic injection, and every 60 min, the extent of the motor block in the recovery room was scored as 1-3, according to a modified Bromage scale. Adverse events and the time to the first analgesic requirement were reported. Patients in the two groups did not differ with respect to age, weight and height. There were no differences in heart rate and arterial pressure between the two groups(P>0.05). No adverse events were observed. The ropivacaine group showed a shorter duration of motor block than the bupivacaine group (P<0.05). The first postoperative analgesic requirement was a mean (sd) of 5 h+/-4.32 after the operation in the ropivacaine group and 5 h+/-3.81 for the bupivacaine group. These findings suggest that caudal anaesthesia with ropivacaine 0.25% in paediatric patients can be effective, with less motor blockade in the postoperative period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320602

Source DB:  PubMed          Journal:  Paediatr Anaesth        ISSN: 1155-5645            Impact factor:   2.556


  8 in total

Review 1.  Ropivacaine: a review of its use in regional anaesthesia and acute pain management.

Authors:  Dene Simpson; Monique P Curran; Vicki Oldfield; Gillian M Keating
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Ropivacaine: an update of its use in regional anaesthesia.

Authors:  K J McClellan; D Faulds
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

Review 3.  Benefit-risk assessment of ropivacaine in the management of postoperative pain.

Authors:  Wolfgang Zink; Bernhard M Graf
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Benefit and risks of local anesthetics in infants and children.

Authors:  Joel B Gunter
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Efficacy of clonidine as an adjuvant to ropivacaine for caudal analgesia in children undergoing subumbilical surgery.

Authors:  Akilandeswari Manickam; Mahesh Vakamudi; Aruna Parameswari; Chetana Chetan
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-04

6.  A Comparative Study of 0.25% Levobupivacaine, 0.25% Ropivacaine, and 0.25% Bupivacaine in Paediatric Single Shot Caudal Block.

Authors:  Jagdeep Sharma; Ruchi Gupta; Anita Kumari; Lakshmi Mahajan; Jasveer Singh
Journal:  Anesthesiol Res Pract       Date:  2018-10-31

7.  Caudal-epidural bupivacaine versus ropivacaine with fentanyl for paediatric postoperative analgesia.

Authors:  Swapnadeep Sengupta; Sudakshina Mukherji; Jagabandhu Sheet; Anamitra Mandal; Sarbari Swaika
Journal:  Anesth Essays Res       Date:  2015 May-Aug

8.  Pre-emptive caudal epidural analgesia with ropivacaine for lumbosacral spine surgery: A randomized case control study.

Authors:  Navneh Samagh; Raghavendra K Pai; Thomas K Mathews; Kiran Jangra; Ravi G Varma
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2018 Apr-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.